XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
New safety information - Product safety
Read the official notice →- Date
- 2022-01-12
- Country
- Canada
- Product
- XELJANZ/XELJANZ XR (tofacitinib)
- Category
- Other
- Source
- Health Canada
Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the brand, model, batch number and pictures against the official notice.
- If yours matches, stop using it and keep it away from children.
- Follow the remedy in the notice: a refund, repair or replacement from the seller or maker. Many recalls also apply to items bought online.
General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.
Other other recalls in Canada
- 2022-01-24
CA
Carrément Beau Raincoat recalled due to entanglement and vehicular dragging hazard
Entanglement hazard
Health CanadaOfficial notice →- 2022-01-21
CA
Dyna-One Energy Absorber Lanyard recalled by manufacturer due to injury hazard
Injury hazard
Health CanadaOfficial notice →- 2022-01-12
CA
Qualipièces brand Rollerski® recalled due to injury hazard
Injury hazard
Health CanadaOfficial notice →- 2022-01-07
CA
Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
New safety information - COVID
Health CanadaOfficial notice →CA
DEWALT ® Jobsite Pro Wireless Earphones recalled due to burn and fire hazard
Burn hazard - Fire hazard
Health CanadaOfficial notice →- 2022-01-06
CA
Equate Dry Mouth Oral Rinse recalled due to microbial contamination
Microbial hazard
Health CanadaOfficial notice →